Molecular basis of IgA nephropathy

被引:14
作者
Lai, ASH [1 ]
Lai, KN [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
IgA nephropathy; IgA; mesangial inflammation; tubulointerstitial injury; electrostatic charge; growth factors; renin-angiotensin system; angiotensin II receptors;
D O I
10.2174/1566524054553450
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide and remains an important cause of end-stage renal failure. However, the basic molecular mechanism(s) underlying abnormal IgA synthesis, selective mesangial deposition with ensuing mesangial cell proliferation and extracellular matrix expansion remains poorly understood. Notably, the severity of tubulointerstitial lesions better predicts the renal progression than the degree of glomerular lesions. The task of elucidating the molecular basis of IgAN is made especially challenging by the fact that both environmental and genetic components likely contribute to the development and progression of IgAN. This review will summarize the earlier works on the structure of the IgA molecule, mechanisms of mesangial IgA deposition and pathophysiologic effects of IgA on mesangial cells following mesangial deposition. Recently, a series of important advances in the area of communication between the glomerular mesangium and renal tubular cells have emerged. These novel findings regarding the molecular pathogenesis of IgAN will be helpful in designing future directions for therapy.
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [1] Progress in Molecular and Genetic Studies of IgA Nephropathy
    Jan Novak
    Bruce A. Julian
    Milan Tomana
    Jiri Mestecky
    Journal of Clinical Immunology, 2001, 21 : 310 - 327
  • [2] Progress in molecular and genetic studies of IgA nephropathy
    Novak, J
    Julian, BA
    Tomana, M
    Mestecky, J
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (05) : 310 - 327
  • [3] Studies of the molecular basis of IgA production, subclass regulation and class-switch recombination in IgA nephropathy patients
    Baskin, B
    Pettersson, E
    Rekola, S
    Smith, CIE
    Islam, KB
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (03) : 509 - 517
  • [4] Future directions in the treatment of IgA nephropathy
    Lai, KN
    NEPHRON, 2002, 92 (02): : 263 - 270
  • [5] The Role of IgA in the Pathogenesis of IgA Nephropathy
    Perse, Martina
    Veceric-Haler, Zeljka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (24)
  • [6] Role of macromolecular IgA in IgA nephropathy
    van der Boog, PJM
    van Kooten, C
    de Futer, JW
    Daha, MR
    KIDNEY INTERNATIONAL, 2005, 67 (03) : 813 - 821
  • [7] Neutrophils in IgA nephropathy
    Lai, KN
    NEPHROLOGY, 1996, 2 : S7 - S11
  • [8] Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
    Suzuki, Hitoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (01) : 26 - 31
  • [9] Treatment of IgA nephropathy
    Barratt, J.
    Feehally, J.
    KIDNEY INTERNATIONAL, 2006, 69 (11) : 1934 - 1938
  • [10] Biomarkers for IgA nephropathy on the basis of multi-hit pathogenesis
    Hitoshi Suzuki
    Clinical and Experimental Nephrology, 2019, 23 : 26 - 31